Regeneron Pharmaceuticals (REGN) Free Cash Flow (QoQ) (2009 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.99% |
| Dec 31, 2025 | -19.67% |
| Sep 30, 2025 | -3.94% |
| Jun 30, 2025 | 46.47% |
| Mar 31, 2025 | -23.27% |
| Dec 31, 2024 | 19.93% |
| Sep 30, 2024 | 163.60% |
| Jun 30, 2024 | -75.61% |
| Mar 31, 2024 | 64.45% |
| Dec 31, 2023 | 16.03% |
| Sep 30, 2023 | -35.79% |
| Jun 30, 2023 | -5.40% |
| Mar 31, 2023 | -24.13% |
| Dec 31, 2022 | 222.31% |
| Sep 30, 2022 | 18.40% |
| Jun 30, 2022 | -79.04% |
| Mar 31, 2022 | -11.62% |
| Dec 31, 2021 | -32.40% |
| Sep 30, 2021 | 649.46% |
| Jun 30, 2021 | -26.28% |
| Mar 31, 2021 | -44.49% |
| Dec 31, 2020 | 362.48% |
| Sep 30, 2020 | -150.09% |
| Jun 30, 2020 | 54.10% |
| Mar 31, 2020 | -18.58% |
| Dec 31, 2019 | 48.85% |
| Sep 30, 2019 | 364.89% |
| Jun 30, 2019 | -88.61% |
| Mar 31, 2019 | 27.89% |
| Dec 31, 2018 | 85.55% |
| Sep 30, 2018 | 22.68% |
| Jun 30, 2018 | -47.61% |
| Mar 31, 2018 | 17.44% |
| Dec 31, 2017 | 29.32% |
| Sep 30, 2017 | 515.81% |
| Jun 30, 2017 | -127.97% |
| Mar 31, 2017 | 27.28% |
| Dec 31, 2016 | -54.93% |
| Sep 30, 2016 | 104.28% |
| Jun 30, 2016 | 541.02% |
| Mar 31, 2016 | -156.81% |
| Dec 31, 2015 | -86.07% |
| Sep 30, 2015 | 4,062.97% |
| Jun 30, 2015 | 108.31% |
| Mar 31, 2015 | -367.74% |
| Dec 31, 2014 | -4.64% |
| Sep 30, 2014 | -68.16% |
| Jun 30, 2014 | 2,450.94% |
| Mar 31, 2014 | -105.31% |
| Dec 31, 2013 | 250.13% |
| Sep 30, 2013 | -35.16% |
| Jun 30, 2013 | 44.07% |
| Mar 31, 2013 | -16.63% |
| Dec 31, 2012 | 717.76% |
| Sep 30, 2012 | 86.16% |
| Jun 30, 2012 | 6.98% |
| Mar 31, 2012 | -59.23% |
| Dec 31, 2011 | -10.74% |
| Sep 30, 2011 | -13.74% |
| Jun 30, 2011 | -49.37% |
| Mar 31, 2011 | 55.21% |
| Dec 31, 2010 | -152.45% |
| Sep 30, 2010 | 504.86% |
| Jun 30, 2010 | -6.53% |
| Mar 31, 2010 | 52.97% |
| Dec 31, 2009 | -113.73% |